A FoxO1-dependent, but NRF2-independent induction of heme oxygenase-1 during muscle atrophy  by Kang, Jione et al.
FEBS Letters 588 (2014) 79–85journal homepage: www.FEBSLetters .orgA FoxO1-dependent, but NRF2-independent induction of heme
oxygenase-1 during muscle atrophy0014-5793/$36.00  2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.febslet.2013.11.009
⇑ Corresponding author. Address: College of Pharmacy, Ewha Womans Univer-
sity, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 120-750, Republic of Korea. Fax: +82
2 3277 3760.
E-mail address: eshwang@ewha.ac.kr (E.S. Hwang).Jione Kang, Mi Gyeong Jeong, Sera Oh, Eun Jung Jang, Hyo Kyeong Kim, Eun Sook Hwang ⇑
College of Pharmacy and Global Top5 Research Program, Ewha Womans University, Seoul 120-750, Republic of Korea
a r t i c l e i n f oArticle history:
Received 5 August 2013
Revised 2 October 2013
Accepted 4 November 2013
Available online 20 November 2013
Edited by Berend Wieringa
Keywords:
Nerve injury
MAFbx
MuRF1
NRF2
FoxO1a b s t r a c t
Skeletal muscle plays key roles in metabolic homeostasis. Loss of muscle mass, called muscle atro-
phy exacerbates disease-associated metabolic perturbations. In this study, we characterized the
molecular functions and mechanisms underlying regulation of skeletal muscle atrophy induced
by denervation. Denervation signiﬁcantly increased the expression of heme oxygenase-1 (HO-1)
and atrogenes in skeletal muscle. Forkhead box protein O1 (FoxO1) drastically increased in atro-
phied muscle and selectively stimulated HO-1 gene transcription through direct DNA binding. Lack
of HO-1 substantially attenuatedmuscle atrophy, whereas HO-1 overexpression caused muscle dam-
age in vitro and in vivo. Collectively, HO-1 induced by FoxO1 may cause skeletal muscle atrophy.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The muscle is an important tissue that stockpiles protein in the
body; however, oxidative stress and denervation cause excessive
protein degradation and induce skeletal muscle wasting [1]. Prote-
olytic systems are primarily responsible for eliminating contractile
proteins and organelles and for shrinkage of muscle ﬁbers [2]. In
particular, two muscle-speciﬁc ubiquitin ligases, MAFbx (muscle
atrophy F-box) and MuRF1 (muscle-speciﬁc RING ﬁnger protein
1), cause proteasomal degradation in skeletal muscle and contrib-
ute to muscle atrophy [3,4]. MAFbx and MuRF1, called atrogenes,
are strongly increased during muscle atrophy through activation
of myogenin [5] and forkhead box protein O (FoxO) [6]. Indeed,
mice lacking MuRF1 or MAFbx revealed protection from denerva-
tion-induced muscle atrophy [3]. FoxO1 transgenic mice showed
markedly decreased skeletal muscle mass, and conversely, FoxO1
knockdown blocked MAFbx up-regulation [7]. In addition,
inﬂammatory cytokines and nuclear factor jB (NF-jB) signaling
pathways are critically involved in muscle atrophy [8,9] through
generation of intracellular reactive oxygen species (ROS) [10].
Dysregulated ROS generation is prominently associated with
severe muscle loss [11].Extensive studies have identiﬁed that nuclear factor erythroid
2-related factor 2 (NRF2)/MAF and its cytosolic repressor, kelch-
like ECH-associated protein 1 (KEAP1), are indispensable for cellu-
lar adaptation to oxidative stress [12]. Oxidative stress dissociates
NRF2 from KEAP1 in the cytosol and induces nuclear localization of
NRF2. Nuclear NRF2 directly binds to the antioxidant response ele-
ment (ARE) within the gene promoter of many antioxidants, such
as heme oxygenase-1 (HO-1) [13], glutathione S-transferase a
(GSTA) 1/2 [14], and NAD(P)H:quinone oxidoreductase 1 (NQO1)
[15], and activates their expression, thereby protecting from oxida-
tive stress-induced tissue injury [16]. Despite the key role of NRF2
in protection from oxidative stress, the importance of NRF2 in
protection from injury-induced muscle atrophy remains unclear.
In this study, we have examined whether NRF2 is involved in pro-
tecting skeletal muscle from denervation-induced muscle atrophy
and characterized the molecular function during muscle atrophy.
2. Materials and methods
2.1. Mice
C57BL/6 WT and NRF2 KO mice were obtained from Jackson
Laboratory (Bar Harbor, ME) and RIKEN BioResource Center
(Tsukuba, Japan) and maintained in an animal facility of Ewha
Womans University. Animal handling was performed in accordance
with the institutional guidelines of and approved by the IACUC
(2011-01-027 and 2012-01-035).
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Mice (12 weeks of age, male, 25–30 g) were anesthetized using
a constant ﬂow of isoﬂurane inhalation. A small incision was made
below the hip bone, parallel to the sciatic nerve. The nerve was iso-
lated by removing any adherent tissue and tightly ligated with 6-0
silk suture thread around one-third to one-half of the diameter of
the sciatic nerve [17]. Separately, the sciatic nerve was exposed,
but not ligated in sham-operated mice. The skin incisions were
closed with surgical suture and wound clips. The mice were main-
tained up to 7 days and were sacriﬁced, followed by analyses of the
tibialis anterior (TA) and gastrocnemius (GN) muscles [11].
2.3. Myogenic differentiation and muscle atrophy in vitro
C2C12 myoblasts (ATCC, Manassas, VA) were grown to 100%
conﬂuence and replaced with myogenic differentiation medium
containing 2% horse serum (Invitrogen, Carlsbad, CA) for 6 days.
Differentiated myocytes were then treated with dexamethasone
(DEX; 500 lM, Sigma–Aldrich, St. Louis, MO) for 24 h to induce
muscle atrophy in vitro.
2.4. Immunoblot analysis
Cell proteins were harvested and resolved by SDS–PAGE, fol-
lowed by immunoblotting. Protein blots were incubated with anti-
body against myosin heavy chain (MyHC; DSHB, Iowa City, IA),
FoxO1 (Cell Signaling Technology, Inc., Danvers, MA), MuRF1
(ECM Biosciences LLC, Versailles, KY), HO-1, MAFbx (Abcam, Cam-
bridge, UK), BACH1, and b-actin (Santa Cruz Biotechnology Inc.)
and subsequently with horseradish peroxidase-conjugated second-
ary antibody, followed by detection with enhanced chemilumines-
cence (Thermo Fisher Scientiﬁc, Rockford, IL).
2.5. Chromatin immunoprecipitation (ChIP)
ChIP was performed as described previously [18]. Brieﬂy, TA
and GN muscles (25 mg) were ﬁnely minced in cold PBS and
cross-linked with 1% formaldehyde. Muscles were homogenized
and immnunoprecipitated using FoxO1 antibody or control IgG.
The input DNA and eluted DNA were used for quantitative PCR
and real time-PCR. Primers for HO-1 promoter were as follows:
HO1-ChIP-FWD 50-tgtgccatcactacccagaa-30 and HO1-ChIP-REV
50-agcagggtaaggcttggaat-30. Relative level was calculated after
normalizing to the input samples.
2.6. Total RNA isolation and real-time PCR
Total RNA was isolated using TRIzol reagent (Invitrogen) and
used for real-time PCR (Applied Biosystems, Foster City, CA). Relative
expression level was determined after normalization with GAPDH
levels. The primer sets used for real time-PCR were as follows: GAP-
DH, 50-tccaccttcgatgccgggg-30 and 50-agcgctattcattgtcatacc-30; GSTA,
50-ggagattgatgggatgaagc-30, 50-aacaccttttcaaaggcagg-30; HO-1,
50-accgccttcctgctcaacattgag-30, 50-tgttcctctgtcagcatcacc-30; IL-1b, 50-
gtgtgccgtctttcattacacag-30, 50-ggacagaatatcaaccaagtgata-30; IL-6, 50-
gaggataccactcccaacaga-30, 50-aagtgcatcatcgttgttcataca-30; MAFbx,
50-aaggctgttggagctgatagca-30, 50-cacccacatgttaatgttgcc-30; MuRF1,
50-tgaccacagagggtaaag-30, 50-tgtctcactcatctccttcttc-30; myogenin, 50-
ccagcccatggtgcccagtg-30, 50-gcgtctgtagggtcagccgc-30; and NQO1, 50-
gacatgaacgtcattctctg-30, 50-ctagctttgatctggttgtc-30.
2.7. Reporter gene assay
293T cells were transiently transfected with mouse HO-1
promoter-linked reporter gene (pHO4.3k-luc) [19] together withNRF2, FoxO1, and/or BACH1 expression vector. pCMV (Invitrogen)
encoding b-galactosidase was cotransfected as an internal control.
Cell extracts were harvested 48 h after transfection and assayed
using the Luciferase Assay kit (Promega, Madison, WI), and the
Galacto-Light b-galactosidase assay kit (Applied Biosystems)
according to the manufacturer’s instructions.
2.8. Immunohistochemistry
TA muscles were ﬁxed with 10% neutralized formalin for 24 h
and embedded in parafﬁn. Tissue sections (5 lm thick) were
prepared and stained with hematoxylin and eosin (HE) solution
(Sigma–Aldrich, St. Louis, MO) and antibody against MyHC, NRF2,
or FoxO1 (Cell signaling), followed by incubation with ﬂuorescence
tagged IgG or peroxide/DAB (Vector Laboratories, Burlingame, CA,
USA).
2.9. Transfection of siRNA
Fully differentiated myocytes from C2C12 cells were transfected
with siRNA using HiPerFect transfection reagents (Qiagen, Hilden,
Germany). Transfected cells were additionally treated with Dex for
24 h. At least three different sets of siRNA for FoxO1 and HO-1 were
synthesized (Bioneer, Daejeon, South Korea): siCon, 50-ccuacgccac-
caauuucgu-30; siFoxO #1, 50-ccagaccaggauaauuggu-30; siFoxO #2,
50-cuaaugugucucaaacauu-30; siFoxO #3, 50-caucuaugcagccuuguuu-
30; siHO-1, 50-cagaucagcacuagcucau-30; siHO-2, 50-caccaaggaggua-
cacauc-30; and siHO-3, 50-ccugaaucgagcagaacca-30.
2.10. Rotarod test
Mice (n = 12) were divided into two groups and injected with
either vehicle or hemin (25 mg/kg) for 10 days. The latency time
it takes the mouse to fall off the rod rotating was measured under
continuous acceleration conditions (4, 7, 10, and 20 rpm for 2 min)
at days 8, 9, 10, 11 and 12 after injection. The average latency time
of each group is expressed as mean ± S.E.M. for 6 mice.
2.11. Statistical analyses
Data are presented as mean ± S.E.M. and analyzed by the un-
paired Student’s t-test.
3. Results
3.1. Sciatic nerve injury induces muscle damage with an increase of
NRF2 and FoxO1
To characterize the molecular mechanisms involved in muscle
atrophy,weperformedsciaticnerve injuryandexamined themuscle
phenotypes. The weights of GN and TA muscles were signiﬁcantly
decreased and MyHC expression decreased at day 7 after nerve in-
jury (Fig. 1A and B). However, the expression of antioxidants, such
as heme oxygenase-1 (HO-1) and catalase was increased (Fig. 1B).
Furthermore, the expression of atrogenes, inﬂammatory cytokines,
and myogenin was signiﬁcantly increased during muscle atrophy
(Fig. 1B and C). Simultaneously, NRF2 and FoxO1 expression, but
not NF-jB p65, were signiﬁcantly augmented in atrophied muscle
andparticularlyenriched in thenucleusof themuscle (Fig. 1DandE).3.2. NRF2 is not required for induction of muscle atrophy markers and
HO-1
Because NRF2 expression is important for protection against
oxidative stress by the induction of antioxidants, we examined
Fig. 1. HO-1 induction in nerve injury-induced muscle atrophy nerve injury was caused in C57BL6 WT mice (NI; n = 15) by tying a tight ligature around the sciatic nerve, and
the mice were sacriﬁced on days 1, 3, and 7 after denervation. Sham-operated mice (sh; n = 15) were used as controls. (A) GN and TA muscles were isolated from the sh and NI
groups, and muscle mass was measured at the indicated time points (n = 5 each). Data are presented as mean ± S.E.M. (B) protein extracts were prepared from the TA and GN
muscle on days 3 and 7 and were used in SDS–PAGE and immunoblotting analysis (n = 3). (C) Total RNA was collected from the muscle at day 7 after injury and reverse-
transcribed. The relative transcript level was calculated after normalization to b-actin level. Data are given as mean ± S.E.M. of 5 mice. (D) At day 3, protein extract was
harvested and analyzed by immunoblotting (n = 3). (E) TA muscle was ﬁxed and sectioned, followed by HE staining and immunohistochemistry with antibodies against
desmin, NRF2, and FoxO1. Scale bars, 200 and 50 lm. Representative images are shown in (B), (D), and (E). ⁄P < 0.05; ⁄⁄P < 0.005; ⁄⁄⁄P < 0.0005.
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Sciatic nerve injury induced similar extents of muscle wasting of
GN and TA muscles in WT and NRF2 KO mice (Fig. 2A). Histological
analysis conﬁrmed muscle damage in both WT and KO muscle
after denervation (Fig. 2B). MyHC decrease was prominent after
nerve injury and induction of MuRF1 and HO-1 was comparable
between WT and NRF2 KO mice (Fig. 2C). In addition, muscle atro-
phy markers and inﬂammatory factors such as IL-6 and myogenin
were similarly expressed in WT and KO muscle after denervation
(Fig. 2C and D). As expected, NRF2 target genes like GSTA1/2 and
NQO1 were increased in injured muscle but their expression
was disappeared in the absence of NRF2 (Fig. 2E). Surprisingly,
however, another known target of NRF2, the heme oxygenase-1
(HO-1) was expressed in NRF2 deﬁciency similar to that in WT
muscle after injury (Fig. 2E), implying no protective role of NRF2
against muscle atrophy and an NRF2-independent induction of
HO-1 in muscle atrophy.
3.3. FoxO1 is important for the induction of HO-1
Because another major regulator of oxidative stress, FoxO1 was
substantially increased in the nucleus of muscle ﬁbers after injury,
we investigated whether FoxO1 could be involved in modulatingHO-1 activity. We found that FoxO1 was substantially increased
after denervation and was comparably expressed in WT and
NRF2 KO muscle (Fig. 3A). Immunoﬂuorescence staining showed
prominent FoxO1 expression in the nucleus of muscle ﬁbers after
injury (Fig. 3B). We then determined whether FoxO1 activated
HO-1 promoter activity. Overexpression of either NRF2 or FoxO1
stimulated HO-1 promoter activity in a dose-dependent manner
(Fig. 3C); however, no cooperative effect was observed between
NRF2 and FoxO1 in the induction of HO-1 promoter activity
(Fig. 3D). Direct binding of FoxO1 to the HO-1 gene promoter
was stimulated in muscle atrophy, as evidenced by ChIP and quan-
titative PCR experiments (Fig. 3E and F). However, it remained un-
clear how FoxO1 substituted NRF2 function to induce HO-1 gene
transcription. We investigated the levels of NRF2 suppressors
KEAP1 and BACH1. KEAP1 expression was low and unchanged in
WT and KO muscle after injury, whereas BACH1 expression was
markedly increased in injured muscle, with comparable levels be-
tween WT and KO muscle (Fig. 3G). Interestingly, NRF2-induced
HO-1 promoter activity was suppressed by BACH1, whereas BACH1
expression had no effect on FoxO1-mediated HO-1 activation
(Fig. 3H). These results indicate that the NRF2 suppression by
BACH1 instigates FoxO1 to induce HO-1 gene transcription during
muscle atrophy.
Fig. 2. NRF2-independent expression of HO-1 in muscle atrophy Sciatic nerve injury (NI) and sham operation (sh) were conducted in WT and NRF2 KO mice (n = 6 each), and
the mice were sacriﬁced at day 7 after injury. (A) The weights of GN and TA muscles were measured, and data are expressed as mean ± S.E.M. of 6 mice. (B) TAZ muscle was
sectioned and stained with HE. (C) Protein extracts were obtained from TA muscle at day 7 and analyzed by SDS–PAGE and immunoblotting (n = 6). Representative blots of 3
independent experiments are shown. (D and E) Total RNA was collected from the muscles of WT and NRF2 KO mice at day 7 after injury and used for real time-PCR. Relative
mRNA level was calculated after normalization to b-actin level. Data are given as mean ± S.E.M. of 6 mice. ns, not signiﬁcant; ⁄P < 0.05; ⁄⁄P < 0.005; ⁄⁄⁄P < 0.0005.
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In order to clarify the importance of FoxO1 in HO-1 induction in
muscle atrophy, we established the muscle atrophy system in vitro
by treating differentiated myocytes with DEX. DEX treatment in-
duced morphological changes of the differentiated myocytes and
decreased expression of MyHC (Fig. 4A). Simultaneously, DEX in-
creased mRNA level of atrogenes and HO-1 in differentiated myo-
cytes (Fig. 4B), mimicking in vivo nerve injury-induced muscle
atrophy. We attempted to conﬁrm the importance of FoxO1 by
determining HO-1 level by the lack of FoxO1. FoxO1 expression
was decreased after transfection with three different types of small
interfering RNA (siRNA) against FoxO1 in fully differentiated myo-
cytes (Fig. 4C). The mRNA level of HO-1 was measured in control
and FoxO1 knockdown myocytes after treatment with DEX. HO-1
expression was induced by DEX, but was not signiﬁcantly induced
in FoxO1 knockdown cells compared in control cells (Fig. 4D), sug-
gesting a necessity of FoxO1 in HO-1 induction.
3.5. Suppression of HO-1 attenuates DEX-induced expression of muscle
atrophy genes
We then assessed the effect of HO-1 in muscle atrophy and
activity. Knockdown of HO-1 in differentiated myocytes signiﬁ-
cantly attenuated the expression of atrogenes induced by DEXtreatment (Fig. 5A and B). Conversely, elevated HO-1 expression
by treatment with hemin, an HO-1 inducer decreased the level of
MyHC but increased MuRF1 through induction of FoxO1 (Fig. 5C).
The ﬂattened shape and shrinking of differentiated myocytes and
MyHC decline were prominently induced after treatment with
hemin (Fig. 5D). More importantly, daily administration of hemin
for 7 days caused muscle damage in vivo, as evidenced by HE stain-
ing and immunohistochemistry of desmin (Fig. 5E). In addition,
physical muscle activity was measured by rotarod test. Latency
time to fall was signiﬁcantly decreased in hemin-injected mice
after day 10 when compared in vehicle-treated group (Fig. 5F).
These results suggest that sustained HO-1 expression by hemin
treatment exerts a deleterious effect on skeletal muscle ﬁbers
and physical muscle activity.
4. Discussion
Our results showed that HO-1 level increased substantially in
muscle atrophy, and its expression was dependent on FoxO1,
but not on NRF2. Blockade of HO-1 induction attenuated muscle
atrophy gene expression induced by DEX treatment in vitro, and
prolonged HO-1 expression per se was sufﬁciently injurious to
the skeletal muscle ﬁbers in vivo.
NRF2 is a major protective molecule against oxidative stress
[20]. To ensure the timely activity of different antioxidants and
detoxifying enzymes, NRF2 activity is tightly controlled by
Fig. 3. FoxO1-induced HO-1 expression after nerve injury (A and B) WT and NRF2 KO mice were sham-operated (sh; n = 6 each) or injured (NI; n = 6 each) and sacriﬁced at
day 7. Protein extracts were analyzed by immunoblotting (A). Tissue sections were stained with FoxO1 antibody and observed under a ﬂuorescence microscope (B). (C and D)
293T cells were transfected with different amounts of either NRF2 or FoxO1 expression vector together with pHO-luc (C) or with the indicated combinations of NRF2 and
FoxO1 (D). pCMVb-gal was cotransfected for normalization of transfection efﬁciency. Relative luciferase activity was determined after normalization to b-galactosidase
activity and expressed as a fold induction normalized to mock control (–). (E and F) TA and GN muscles used for preparing genomic DNA. PCR reactions were carried out 26
cycles (E) and quantitatively determined by real time-PCR (F). (G) protein blots in (A) were incubated with antibody against BACH1, KEAP1, and actin. (H) 293T cells were
transfected with expression vector for NRF2, FoxO1, and/or BACH1 together with pHO-luc and pCMVb-gal. Relative activity is expressed as mean ± S.E.M. of 3 independent
experiments. Representative images are shown in (A) to (C), (E) and (G). ns, not signiﬁcant; ⁄P < 0.05; ⁄⁄P < 0.005.
Fig. 4. Necessity of FoxO1 in DEX-induced HO-1 expression in vitro Differentiation of myocytes was induced from C2C12 cells for 6 days and treated with DEX (500 lM) for
24 h. (A) Cells were ﬁxed and incubated with MyHC antibody and DAPI, followed by a microscopic observation. (B) Total RNA was collected and used for determining the
relative expression level. (C and D) Differentiated myocytes were transfected with siRNA against control gene (siCon) or FoxO1 (siFoxO1) and treated with DEX for 24 h.
Protein extracts (C) and total RNA (D) were analyzed. ns, not signiﬁcant; ⁄P < 0.05; ⁄⁄⁄P < 0.0005.
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cytoplasm. NRF2 is also suppressed by BACH1, which competi-
tively binds to ARE and suppresses ARE-regulated gene expression[21]. NRF2 KO mice showed increased susceptibility to a variety of
chemical-induced diseases, such as drug-induced liver injury [22],
oxidative stress-induced cardiomyopathy [23], and cigarette
Fig. 5. Modulation of muscle atrophy by HO-1 in vitro and in vivo (A and B) Differentiated myocytes were transfected with siRNAs and subsequently treated with DEX
(500 lM). Protein extract and total RNA were prepared from the cells and analyzed by immunoblotting (A) and real time-PCR (B). Relative expression levels of MuRF1 and
MAFbx were calculated after normalization to b-actin level. Data are given as mean ± S.E.M. of 3 independent experiments. ⁄P < 0.05; ⁄⁄P < 0.005; ⁄⁄⁄P < 0.0005. (C and D)
Differentiated cells were treated with hemin for 24 h, and protein extracts were harvested for immunoblotting analysis (C). Cells were stained with MyHC antibody and DAPI
and observed under a microscope (D). (E) Hemin (30 mg/kg) was daily injected into the mice for 7 days. TA muscle was sectioned and subjected to HE and desmin staining.
Scale bars indicate 2000, 200, and 50 lm. Representative images are shown in (A) and (C) to (E). (F) Latency time was determined in veh- or hemin-treated mice by Rota rod
test at days 10, 11, 12, and 13 after injection. Data are given as mean ± S.E.M. of 6 mice. ⁄P < 0.05.
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NRF2 against tissue injury. However, abrogation of NRF2 in mice
showed muscle wasting, induction of inﬂammatory and atrophy
markers as comparable as in WT mice after injury. Despite a piv-
otal role of NRF2 in the control of oxidative damage, NRF2 is nei-
ther necessary nor sufﬁcient for protecting against nerve injury-
induced muscle atrophy. Interestingly, the expression of GSTA1/2
and NQO1 was impaired in NRF2 deﬁciency whereas HO-1 was in-
creased in NRF2 KO muscle after injury.
Denervation caused an increase in expression level and nuclear
localization of NRF2, resulting in the expression of antioxidants
such as GSTA1/2, NQO1, and HO-1. However, injured muscle sub-
sequently increased expression of BACH1, an NRF2 competitor,
thereby attenuating NRF2 activity to bind to ARE and induce
ARE-mediated gene transcription. Although the expression level
of GSTA1/2 and NQO1 was reciprocally regulated by NRF2 and
BACH1, HO-1 expression was not suppressed by BACH1 but rather
increased in denervation-induced muscle atrophy. Our results
demonstrated that FoxO1 directly bound to FRE within the HO-1gene promoter and stimulated HO-1 gene transcription even in
the presence of BACH1 (Fig. 6). In addition, FoxO1 strongly in-
creased the expression of MAFbx and caused muscle atrophy. In-
duced expression of FoxO1 played important role in the
induction of not only MAFbx, an atrophy marker but also HO-1
in muscle after denervation.
There have been extensive studies on protective roles of HO-1
in many tissues. NRF2-dependent HO-1 expression profoundly
attenuated lung injury, skin lesion, and cardiac failure [25]. Fur-
thermore, abrogation of HO-1 in mice developed fulminant renal
failure, leading to death [26] and exacerbated atherosclerosis in
an apolipoprotein E-deﬁcient genetic background [27]. HO-1 is
an indispensable stress response protein. However, HO-1 expres-
sion decreased the viability of myocytes [28] and inhibited myo-
blast differentiation [29]. In addition, HO-1 induction exacerbates
early brain injury [30]. Our results also revealed that HO-1 expres-
sion was increased by FoxO1 in muscle atrophy in vivo, and sup-
pression of HO-1 level in fully differentiated myocytes
attenuated the induction of MAFbx and MuRF1 after DEX
Fig. 6. FoxO1-induced expression of HO-1 and muscle atrophy genes Under basal
conditions, nuclear NRF2 is competed by BACH1 for binding to ARE within the
promoter of HO-1, GSTA1/2, and NQO1 genes, resulting in low expression of
antioxidants. Upon injury, the expression of NRF2 and FoxO1 was increased in
muscle. NRF2 is essential for the expression of protective antioxidants such as
GSTA1/2 and NQO1 but is not required for HO-1 expression. FoxO1, on the other
hand, directly binds to FRE within the promoter of HO-1 and MAFbx genes and
promotes gene transcription, thereby inducing muscle atrophy.
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treatment with hemin was accompanied by a decrease in MyHC
and an increase in atrogenes, causing skeletal muscle atrophy.
HO-1 thus has a dual and opposing role, it provides protection from
oxidative damage in an NRF2-dependent manner and it promotes
muscle atrophy through a FoxO1-induced pathway.
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